A second vaccine was introduced by the Democratic Republic of Congo on Thursday introduced to help fight Ebola in the east of the country, Doctors Without Borders (MSF) said.
The new vaccine, produced by a Belgian subsidiary of Johnson & Johnson, will be administered to about 50,000 people over four months, the charity said.
More than a quarter of a million people, many of them frontline health workers, have been immunised with another anti-Ebola vaccine in a programme begun last year.
The epidemic began in August 2018 in the province of North Kivu before spreading to neighbouring Ituri and South Kivu — a remote and largely lawless region bordering Uganda, Rwanda and Burundi.
The notorious haemorrhagic virus has so far killed 2,193 people, according to the latest official figures.
It is the DRC’s 10th Ebola epidemic and the second deadliest on record after an outbreak that struck West Africa in 2014-16, claiming more than 11,300 lives.[gm_article_]